ResMed Total Current Assets 2010-2024 | RMD

ResMed total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • ResMed total current assets for the quarter ending September 30, 2024 were $2.641B, a 14.6% increase year-over-year.
  • ResMed total current assets for 2024 were $2.358B, a 0.43% decline from 2023.
  • ResMed total current assets for 2023 were $2.368B, a 22.59% increase from 2022.
  • ResMed total current assets for 2022 were $1.931B, a 22.65% increase from 2021.
ResMed Annual Total Current Assets
(Millions of US $)
2024 $2,358
2023 $2,368
2022 $1,931
2021 $1,575
2020 $1,523
2019 $1,145
2018 $1,066
2017 $1,644
2016 $1,420
2015 $1,408
2014 $1,556
2013 $1,449
2012 $1,361
2011 $1,292
2010 $985
2009 $853
ResMed Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $2,641
2024-06-30 $2,358
2024-03-31 $2,351
2023-12-31 $2,378
2023-09-30 $2,305
2023-06-30 $2,368
2023-03-31 $2,338
2022-12-31 $2,325
2022-09-30 $2,034
2022-06-30 $1,931
2022-03-31 $1,704
2021-12-31 $1,547
2021-09-30 $1,586
2021-06-30 $1,575
2021-03-31 $1,466
2020-12-31 $1,451
2020-09-30 $1,543
2020-06-30 $1,523
2020-03-31 $1,470
2019-12-31 $1,300
2019-09-30 $1,161
2019-06-30 $1,145
2019-03-31 $1,103
2018-12-31 $1,064
2018-09-30 $1,088
2018-06-30 $1,066
2018-03-31 $1,604
2017-12-31 $1,754
2017-09-30 $1,658
2017-06-30 $1,644
2017-03-31 $1,605
2016-12-31 $1,520
2016-09-30 $1,475
2016-06-30 $1,420
2016-03-31 $1,400
2015-12-31 $1,351
2015-09-30 $1,533
2015-06-30 $1,408
2015-03-31 $1,553
2014-12-31 $1,558
2014-09-30 $1,535
2014-06-30 $1,556
2014-03-31 $1,564
2013-12-31 $1,564
2013-09-30 $1,558
2013-06-30 $1,449
2013-03-31 $1,580
2012-12-31 $1,530
2012-09-30 $1,450
2012-06-30 $1,361
2012-03-31 $1,326
2011-12-31 $1,247
2011-09-30 $1,143
2011-06-30 $1,292
2011-03-31 $1,203
2010-12-31 $1,145
2010-09-30 $1,069
2010-06-30 $985
2010-03-31 $1,030
2009-12-31 $928
2009-09-30 $940
2009-06-30 $853
2009-03-31 $728
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $34.955B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.157B 25.91
Stryker (SYK) United States $148.171B 33.39
Boston Scientific (BSX) United States $133.131B 38.28
EssilorLuxottica (ESLOY) France $113.461B 0.00
Medtronic (MDT) Ireland $109.010B 16.19
Haleon (HLN) United Kingdom $42.913B 27.88
Lonza Group Ag (LZAGY) Switzerland $42.122B 0.00
GE HealthCare Technologies (GEHC) United States $37.701B 19.56
Terumo (TRUMY) Japan $29.203B 41.24
Koninklijke Philips (PHG) Netherlands $24.410B 18.68
Zimmer Biomet Holdings (ZBH) United States $22.087B 14.06
Insulet (PODD) United States $18.377B 73.18
Baxter (BAX) United States $16.604B 10.80
Smith & Nephew SNATS (SNN) United Kingdom $11.153B 0.00
BellRing Brands (BRBR) United States $9.468B 37.96
Bio-Rad Laboratories (BIO) United States $8.977B 30.51
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $5.523B 12.83
TG Therapeutics (TGTX) United States $4.720B 0.00
Haemonetics (HAE) United States $4.260B 20.79
ICU Medical (ICUI) United States $4.155B 39.56
Prestige Consumer Healthcare (PBH) United States $4.074B 20.26
Perrigo (PRGO) Ireland $3.716B 10.94
Envista Holdings (NVST) United States $3.487B 25.97
Neogen (NEOG) United States $3.270B 37.72
Agios Pharmaceuticals (AGIO) United States $3.103B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.789B 17.89
QuidelOrtho (QDEL) United States $2.595B 16.70
Warby Parker (WRBY) United States $2.344B 0.00
LeMaitre Vascular (LMAT) United States $2.332B 56.69
Green Thumb Industries (GTBIF) United States $1.964B 34.37
AtriCure (ATRC) United States $1.772B 0.00
InMode (INMD) Israel $1.487B 8.94
Curaleaf Holdings (CURLF) Canada $1.348B 0.00
AdaptHealth (AHCO) United States $1.311B 9.37
Maravai LifeSciences Holdings (MRVI) United States $1.168B 0.00
BioLife Solutions (BLFS) United States $1.041B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.957B 7.48
CeriBell (CBLL) United States $0.916B 0.00
National Vision Holdings (EYE) United States $0.888B 29.68
Capricor Therapeutics (CAPR) United States $0.839B 0.00
Evolus (EOLS) United States $0.785B 0.00
Verano Holdings (VRNOF) United States $0.608B 0.00
Cresco Labs (CRLBF) United States $0.596B 0.00
VAREX IMAGING (VREX) United States $0.596B 26.47
Surmodics (SRDX) United States $0.559B 0.00
Quanterix (QTRX) United States $0.424B 0.00
Canopy Growth (CGC) Canada $0.404B 0.00
Valneva SE (VALN) France $0.370B 0.00
ZimVie (ZIMV) United States $0.363B 30.63
Omeros (OMER) United States $0.349B 0.00
Viemed Healthcare (VMD) United States $0.335B 31.89
Biote (BTMD) United States $0.330B 7.25
Sanara MedTech (SMTI) United States $0.323B 0.00
Cerus (CERS) United States $0.312B 0.00
OraSure Technologies (OSUR) United States $0.288B 19.30
Zynex (ZYXI) United States $0.249B 52.13
TerrAscend (TSNDF) Canada $0.243B 0.00
Aurora Cannabis (ACB) Canada $0.229B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.15
MacroGenics (MGNX) United States $0.218B 0.00
High Tide (HITI) Canada $0.215B 89.00
Sanuwave Health (SNWV) United States $0.195B 2.74
Jin Medical (ZJYL) China $0.188B 0.00
Zevia PBC (ZVIA) United States $0.162B 0.00
Brainsway (BWAY) Israel $0.161B 96.70
Organigram Holdings (OGI) Canada $0.158B 0.00
FitLife Brands (FTLF) United States $0.143B 17.98
TriSalus Life Sciences (TLSI) United States $0.126B 0.00
Quipt Home Medical (QIPT) United States $0.106B 0.00
Fonar (FONR) United States $0.093B 10.54
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.00
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.082B 0.00
Rockwell Medical (RMTI) United States $0.080B 41.50
Modular Medical (MODD) United States $0.073B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Cellectar Biosciences (CLRB) United States $0.066B 0.00
InterCure (INCR) Israel $0.063B 0.00
Exagen (XGN) United States $0.062B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
Apyx Medical (APYX) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.026B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.17
SNDL (SNDL) Canada $0.000B 0.00